NCT07789795

Brief Summary

This randomized controlled study aims to compare the intraoperative hemodynamic effects of unilateral and bilateral spinal anesthesia in elderly patients undergoing elective total hip arthroplasty. Seventy-four patients aged 65 years and older will be randomized into two groups: unilateral spinal anesthesia (n=37) and bilateral spinal anesthesia (n=37). Hemodynamic parameters including cardiac output, stroke volume, stroke volume variation, pulse pressure variation, and systemic vascular resistance will be continuously monitored using the Pressure Recording Analytical Method (PRAM)-based MostCare monitoring system. Intraoperative fluid requirements and vasopressor consumption will also be evaluated. The study seeks to determine whether unilateral spinal anesthesia provides greater hemodynamic stability and reduces the need for fluid administration and vasopressor support compared with conventional bilateral spinal anesthesia in elderly patients undergoing hip arthroplasty.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P50-P75 for not_applicable

Timeline
0mo left

Started May 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress99%
May 2026Aug 2026

Study Start

First participant enrolled

May 1, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 11, 2026

Completed
3 months until next milestone

First Posted

Study publicly available on registry

August 27, 2026

Completed
4 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2026

Last Updated

August 27, 2026

Status Verified

June 1, 2026

Enrollment Period

4 months

First QC Date

June 11, 2026

Last Update Submit

August 24, 2026

Conditions

Keywords

Unilateral Spinal AnesthesiaBilateral Spinal AnesthesiaPRAMHemodynamic MonitoringStroke Volume VariationPulse Pressure VariationVazopressor Requirement

Outcome Measures

Primary Outcomes (13)

  • Cardiac Index Measured Using PRAM During Spinal Anesthesia

    Cardiac index will be measured using the Pressure Recording Analytical Method (PRAM) and reported in L/min/m². Measurements recorded at each study time point will be compared between the unilateral and bilateral spinal anesthesia groups.

    From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.

  • Stroke Volume Index Measured Using PRAM During Spinal Anesthesia

    Stroke volume index will be measured using the Pressure Recording Analytical Method (PRAM) and reported in mL/beat/m². Measurements recorded at each study time point will be compared between the unilateral and bilateral spinal anesthesia groups.

    From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.

  • Stroke Volume Variation Measured Using PRAM During Spinal Anesthesia

    Stroke volume variation will be measured using the Pressure Recording Analytical Method (PRAM) and reported as a percentage. Measurements recorded at each study time point will be compared between the unilateral and bilateral spinal anesthesia groups.

    From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.

  • Pulse Pressure Variation Measured Using PRAM During Spinal Anesthesia

    Pulse pressure variation will be measured using the Pressure Recording Analytical Method (PRAM) and reported as a percentage. Measurements recorded at each study time point will be compared between the unilateral and bilateral spinal anesthesia groups.

    From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.

  • Systemic Vascular Resistance Measured Using PRAM During Spinal Anesthesia

    Systemic vascular resistance will be measured using the Pressure Recording Analytical Method (PRAM) and reported in dyn·s/cm⁵. Measurements recorded at each study time point will be compared between the unilateral and bilateral spinal anesthesia groups.

    From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.

  • Oxygen Delivery Index Measured Using PRAM During Spinal Anesthesia

    Oxygen delivery index will be measured using the Pressure Recording Analytical Method (PRAM) and reported in mL/min/m². Measurements recorded at each study time point will be compared between the unilateral and bilateral spinal anesthesia groups.

    From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.

  • Arterial Elastance Measured Using PRAM During Spinal Anesthesia

    Arterial elastance will be measured using the Pressure Recording Analytical Method (PRAM) and reported in mmHg/mL. Measurements recorded at each study time point will be compared between the unilateral and bilateral spinal anesthesia groups.

    From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.

  • Maximum Rate of Arterial Pressure Rise Measured Using PRAM

    The maximum rate of arterial pressure rise (dP/dtmax) will be measured using the Pressure Recording Analytical Method (PRAM) and reported in mmHg/s. Measurements recorded at each study time point will be compared between the unilateral and bilateral spinal anesthesia groups.

    From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.

  • Cardiac Cycle Efficiency Measured Using PRAM

    Cardiac cycle efficiency (CCE) will be measured using the Pressure Recording Analytical Method (PRAM) and reported as a dimensionless value. Measurements recorded at each study time point will be compared between the unilateral and bilateral spinal anesthesia groups.

    From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.

  • Oxygen Delivery Measured Using PRAM During Spinal Anesthesia

    Oxygen delivery (DO₂) will be measured using the Pressure Recording Analytical Method (PRAM) and reported in mL/min. Measurements recorded at each study time point will be compared between the unilateral and bilateral spinal anesthesia groups.

    From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.

  • Mean Arterial Pressure During Spinal Anesthesia

    Mean arterial pressure (MAP) will be measured using invasive arterial pressure monitoring and reported in mmHg. Measurements recorded at each study time point will be compared between the unilateral and bilateral spinal anesthesia groups.

    From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.

  • Heart Rate During Spinal Anesthesia

    Heart rate (HR) will be recorded using standard perioperative monitoring and reported in beats per minute. Measurements recorded at each study time point will be compared between the unilateral and bilateral spinal anesthesia groups.

    From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.

  • Peripheral Oxygen Saturation During Spinal Anesthesia

    Peripheral oxygen saturation (SpO₂) will be measured using pulse oximetry and reported as a percentage. Measurements recorded at each study time point will be compared between the unilateral and bilateral spinal anesthesia groups.

    From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.

Study Arms (2)

Unilateral Spinal Anesthesia

EXPERIMENTAL

Patients receive unilateral spinal anesthesia and hemodynamic parameters are monitored using the PRAM method during surgery.

Procedure: Unilateral Spinal Anesthesia

Bilateral Spinal Anesthesia

EXPERIMENTAL

Patients receive bilateral spinal anesthesia and hemodynamic parameters are monitored using the PRAM method during surgery.

Procedure: Bilateral Spinal Anesthesia

Interventions

Unilateral spinal anesthesia administered for unilateral lower extremity surgery.

Unilateral Spinal Anesthesia

Bilateral spinal anesthesia administered for unilateral lower extremity surgery.

Bilateral Spinal Anesthesia

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Adults aged 65 years and older.
  • Patients scheduled for elective total hip arthroplasty.
  • Patients with an American Society of Anesthesiologists (ASA) physical status classification of II, III, or IV.
  • Patients with a Glasgow Coma Scale (GCS) score of 13-15 who are conscious and able to cooperate.
  • Patients with suitable peripheral arterial anatomy for PRAM monitoring.
  • Patients who provide written informed consent to participate in the study.
  • Patients without any clinical contraindication to spinal anesthesia. -

You may not qualify if:

  • Glasgow Coma Scale (GCS) score \<13.
  • Age below 65 years.
  • History of previous major neurosurgical intervention.
  • Anatomical abnormality, vascular defect, or infection at the site intended for arterial catheter placement for PRAM monitoring.
  • Severe spinal deformity (e.g., severe scoliosis, previous spinal fusion surgery, or spinal trauma).
  • Current anticoagulant therapy or coagulopathy (INR \>1.5 or platelet count \<75,000/mm³).
  • Presence of skin infection or systemic infection/sepsis.
  • Severe hypovolemia or decompensated cardiac disease in which spinal anesthesia is contraindicated.
  • Known allergy or hypersensitivity to local anesthetics or sedative agents.
  • Local infection or wound at the planned spinal puncture site.
  • Clinical contraindication to spinal anesthesia (e.g., increased intracranial pressure, septicemia, or severe hypotension). -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kayseri City Hospital

Kayseri, Kayseri, Turkey (Türkiye)

RECRUITING

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
resident physician

Study Record Dates

First Submitted

June 11, 2026

First Posted

August 27, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

August 31, 2026

Study Completion (Estimated)

August 31, 2026

Last Updated

August 27, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations